John R. Corboy, MDProfessor, Neurology, University of Colorado School of MedicineCo-Director, Rocky Mountain MS Center at Anschutz Medical Campus Boulder, CO The coronavirus disease 2019 (COVID-19) pandemic of 2019–2020 (so far) has resulted in radical changes for many segments of society around the world. Included among them are aging physicians. This commentary…
Background and ObjectivesPrevious studies have linked the MRI measures of perivascular spaces (PVSs), diffusivity along the perivascular spaces (DTI-ALPS), and free water (FW) to cerebral…
Dr. Jeff Ratliff talks with Dr. Chris Gibbons about the use of skin biopsies to detect phosphorylated α-synuclein in individuals with synucleinopathies such as Parkinson…
In August 2022, Idha Sood, SIGN chapter President from Christian Medical College in Ludhiana, India stumbled upon a post from Marjorie Fitzsimmons, SIGN chapter President…
Acute disseminated encephalomyelitis (ADEM) is one characteristic manifestation of myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD). A previously healthy man presented with retro-orbital headache and urinary…
Background and ObjectivesStroke attributable to nonoptimal temperature needs more attention with dramatic climate change. The aim of this study was to estimate the global burden…
Background and ObjectivesCognitive impairments are common in idiopathic REM sleep behavior disorder (iRBD), in which the cholinergic degeneration of nucleus basalis of Meynert (NBM) may…
A 63-year-old otherwise healthy woman developed left-sided facial spasm and glossopharyngeal neuralgia 14 and 8 years ago, respectively, followed by right-sided facial spasm 1 year…
A 32-year-old woman presented with subacute dizziness, dysarthria, and unsteady gait, accompanied by progressive headache and memory loss. No facial paresthesia, diplopia, or urinary incontinence…
Introduction and Problem StatementNeurocritical care (NCC) is a niche clinical subspecialty dependent on interdisciplinary cohesion to operate in critical situations. Team cohesion in an intensive…
Background and ObjectivesLittle is known regarding the cost-effectiveness of lecanemab (Leqembi), a monoclonal antibody approved by the US Food and Drug Administration in January 2023…
